Vijay Welle

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: United States

Consulting Services

Scientific Writing Hospital-Pharmacy-Insurance Pharma-CRO-Device

Areas Of Interest

Theories, Nursing Pediculari Pilus, Conjugative Intrusions, Tooth epsilon-Crystallin Underserved Area, Medically Crasnitin MafB Proteins Pre B Cell Growth Stimulating Factor Commission, Governmental Mougeotia BM28, Nuclear Protein Counting, Scintillation Growth, Population Epidemiologic Biase Regulatory Networks, Gene Mangrove Swamps D Cells, Gastric Hyperplasias, Thymic Lobosea Monitoring, Metacognitive S Adenosylmethionine Sulfate Tosylate Aortic Incompetence Photosynthesis Dark Reaction Maternal Serum Screening Tests Taeniases Leigh Syndrome Amylopectin Branching Enzyme Facilities, Industrial Program, Weight Reduction MT3-Matrix Metalloproteinase DRIP205 Eukaryotic Initiation Factor EIF-4A Isocitratase Vaporization, Laser Syndromes, Collodion Baby Corpus Luysi Physical Ergonomic FML Liquifilm Preparations, Pharmaceutic

Professional Narrative

Dr. Vijay Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1990
Assistant Professor, Mayo Clinic 2007

Education

Doctor of osteopathic medicine, Harvard Medical School 1987
Doctor of osteopathic medicine, Weill Medical College 2003

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :